). Protection from inactivation by the competitive inhibitor benzohydroxamate, trypsinolysis and electrospray ionization tandem mass spectrometry analyses, and X-ray crystallographic studies reveal that 3-HP undergoes Schiff-base formation with Lys 166 at the active site, followed by formation of an aldehyde/enol(ate) adduct. Such a reaction is unprecedented in the enolase superfamily and may be a relic of an activity possessed by a promiscuous progenitor enzyme. The ability of MR to form and deprotonate a Schiff-base intermediate furnishes a previously unrecognized mechanistic link to other α/β-barrel enzymes utilizing Schiff-base chemistry and is in accord with the sequence-and structure-based hypothesis that members of the metal-dependent enolase superfamily and the Schiff-baseforming N-acetylneuraminate lyase superfamily and aldolases share a common ancestor.
One of the first enzyme superfamilies recognized was the enolase superfamily, 1 whose members share a common partial reaction (i.e., the metal-assisted, Brønsted-base-catalyzed abstraction of the α-proton from a carboxylate substrate to form an enolate) [2] [3] [4] [5] and a common protein fold [i.e., a modified (α/β)8-barrel (TIM barrel) bearing the catalytic residues at the C-terminal ends of the β-strands and an N-terminal domain that caps the active site conferring substrate specificity and excluding solvent]. [6] [7] [8] Studies of members of the enolase superfamily have afforded important insights into enzyme evolution and developing strategies for assigning the correct functions to proteins identified in genome projects. 3, [9] [10] [11] [12] The well-characterized archetype of this superfamily, mandelate racemase (MR, EC 5.1.2.2) from Pseudomonas putida, catalyzes the Mg 2+ -dependent, 1,1-proton transfer reaction that interconverts the enantiomers of mandelate and has served as a useful paradigm for understanding how enzymes catalyze the rapid α-deprotonation of a carbon acid substrate with a relatively high pKa value. 13 MR utilizes a two-base mechanism with Lys 166 and His 297 abstracting the α-proton from (S)-and (R)-mandelate, respectively (Scheme 1). A variety of β/γ-unsaturated compounds, [14] [15] [16] [17] [18] [19] [20] [21] as well as trifluorolactate, 22 serve as substrates for the enzyme. Recently, we showed that the substrate-product analogue 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propionate [TFHTP (Chart 1)] is a potent competitive inhibitor of MR (Ki = 27 μM) and that its unexpectedly high binding affinity arises from both intimate interactions between the trifluoromethyl groups and the hydrophobic pocket at the active site, and formation of salt bridges between the carboxylate of TFHTP and the active site Brønsted acid-base catalysts Lys 166 and His 297. 23 Recognizing that these active site bases can be exploited as binding determinants for inhibitors, we showed that tartronate is also a competitive inhibitor of MR (Ki = 1.8 mM), binding with its glycolate moiety chelating the Mg 2+ ion and with the remaining carboxylate group interacting with and bridging the active site Brønsted acid-base catalysts. 23 Our interest in understanding the role of the active site Brønsted acid-base catalysts as binding determinants led us to interrogate the active site using three-carbon α-keto acids as tartronate analogues. Most unexpectedly, we discovered that 3-hydroxypyruvate (3-HP) is an irreversible inhibitor of MR, reacting at the active site to form a Schiff-base intermediate that is subsequently deprotonated to form an aldehyde/enol(ate) adduct. Such a reaction has not been reported previously for any member of the enolase superfamily and suggests a mechanistic link to other enzyme superfamilies utilizing Schiff-base chemistry. 
Materials and Methods

General
(R)-Mandelic acid, lithium 3-hydroxypyruvate (3-HP), sodium mesoxalate monohydrate, benzoylformic acid, sodium pyruvate, benzohydroxamic acid, sodium 3-fluoropyruvate monohydrate (3-FP), and all other reagents, unless mentioned otherwise, were purchased from Sigma-Aldrich Canada Ltd. Circular dichroism (CD)-based assays were conducted using a JASCO J-810 spectropolarimeter with a thermostated, water-jacketed cell holder. High-resolution electrospray ionization (ESI) mass spectrometry (MS) was conducted using a Brüker microTOF Focus orthogonal ESI-time-of-flight mass spectrometer operating in positive ion mode. accessed by following the link in the citation at the bottom of the page.
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Concentration Correction for 3-HP
Elemental analysis (Canadian Microanalytical Services Inc.) was conducted on the lithium salt of 3-HP purchased from Sigma-Aldrich to obtain an accurate estimate of the extent of hydration. On the basis of the presence of 26.13% carbon and 3.63% hydrogen in the sample, the calculated molecular weight of 3-HP was 137.89, which corresponds to C3H3O4Li·∼1.5H2O.
Site-Directed Mutagenesis
The pET52b(+)-wtMR plasmid 24 was used as the template to create the H297N mandelate racemase (MR) mutant by performing polymerase chain reaction (PCR)-based site-directed mutagenesis using the QuikChange Site-directed Mutagenesis Kit (Stratgene) and following the protocols described by the manufacturer. Polymerase chain reactions were conducted using PfuTurbo DNA polymerase (Bio Basic Inc.). The forward and reverse synthetic deoxyoligonucleotide primers (Integrated DNA Technologies, Inc.) used to construct the mutant were 5′-CCAATGTCCAGCAACCTGTTCCAAGAAATCAGC-3′ and 5′-GCTGATTTCTTGGAACAGGTTGCTGGACATTGG-3′, respectively. The codons specifying the relevant amino acid are underlined, and the altered bases are given in boldface. Potential mutant plasmids were used to transform competent Escherichia coli DH5α cells. DH5α cells were used for plasmid maintenance and for all sequencing reactions. The mutant open reading frame was sequenced using commercial automated DNA sequencing (Robarts Research Institute) to ensure that no other alterations of the nucleotide sequence had been introduced.
Enzyme Purification
Recombinant wild-type (wtMR) and H297N MR from Pseudomonas putida were overexpressed in and purified from E. coli BL21(DE3) cells transformed with the pET-52b(+)-wtMR and pET52b(+)-H297N-MR plasmids, respectively. The pET-52b(+)-wtMR plasmid containing the MR variant open reading frame encodes the MR gene product (MASWSHPQFEKGALEVLFQGPGYHM1...MR) with an N-accessed by following the link in the citation at the bottom of the page.
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terminal StrepII tag (underlined; M1 represents the first amino acid of wild-type MR). 24 The wild-type and mutant enzymes were purified by affinity chromatography using Strep-Tactin Superflow resin (IBA GmbH) and an ÄKTA FPLC instrument (GE Healthcare) as described previously. 24 Upon elution from the column, the enzyme was dialyzed against storage buffer [100 mM HEPES buffer (pH 7.5) containing 3.3 mM MgCl2, 200 mM NaCl, and 10% (v/v) glycerol] and stored at −20 °C. The purity of the enzyme preparation (≥99%) was checked using 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). StrepII-tagged MR has the same activity as the wildtype enzyme; 24 consequently, the StrepII tag was not removed from the enzymes.
Enzyme Assays
MR activity was assayed using a CD-based assay by following the change in ellipticity of mandelate at 262 nm using a thermostated quartz cuvette with a 1-cm light path (unless otherwise indicated) as described by Sharp et al. 25 All assays (total volume of 2 mL) were conducted at 25 °C in Na 1-cm light path (0.5-cm light path length when the inhibition by benzoylformate was assessed). The final concentrations of MR, BSA, inhibitor, and (R)-mandelate in the 2.0 mL assay mixture were 3.3 nM, 0.005% (w/v), 1.0 μM (except for that of 3-HP, which was 0.8 μM), and 10 mM, respectively. Simultaneously, a control reaction mixture containing wild-type MR (32.7 nM) was incubated in assay buffer at 25 °C for 0 and 30 min to determine the rate of loss of MR activity under the incubation conditions in the absence of inhibitor. Similar time-dependent inhibition experiments were also conducted for pyruvate, mesoxalate, benzoylformate, and 3-FP at a greater inhibitor concentration (2 mM) for 0 and 10 min. The final concentrations of MR, inhibitor, and (R)-mandelate were equal to 3.3 nM, 0.2 mM, and 10 mM, respectively, in a total reaction volume of 2.0 mL for the activity assays.
Inhibition of MR by Mesoxalate and 3-FP
Inhibition experiments were conducted in Na 
Inactivation of MR by 3-HP
The kinetic parameters for the time-dependent inhibition of MR by 3-HP were determined by incubating wild-type MR (32.7 nM) with (6) MR (32.7 nM) that had been completely inactivated by 3-HP (15.95 μM) was dialyzed for 4.5 and 10.5 h at 4 °C against HEPES assay buffer (pH 7.5) to test the reversibility of the inhibition. After dialysis, no significant MR activity was regained relative to that of a control sample containing wild-type MR in the absence of 3-HP. 
Inactivation of MR by 3-HP in the Presence of Benzohydroxamate (BzH)
MR
Mass Spectrometry Analysis of MR Inactivated by 3-HP
Wild-type MR (0.7 mg/mL) and H297N MR (0.98 mg/mL) were incubated with 3-HP (4.0 mM) at 25 °C until the activity of wild-type MR was undetectable using the CD-based assay [assay concentrations of MR and (R)-mandelate of 327 nM and 10 mM, respectively]. A control sample containing wild-type MR was incubated for the same time period in the absence of 3-HP. After complete inactivation of wildtype MR by 3-HP, an aliquot (20 μL) was removed from each reaction mixture and subjected to SDS-PAGE (12%).
In-Gel Digestions
Gel bands from SDS-PAGE corresponding to MR and H297N MR were excised from the gel and rinsed with deionized water (2 × 300 μL). The excised gel strips were then cut into cubes (∼1 mm 3 ) and processed using an automated system for conducting in-gel protein digestions (Investigator Progest, Genomic Solutions). Briefly, the protein in the gel cubes was reduced using dithiothreitol (10 mM), carboxamidomethylated using iodoacetamide (100 mM), and digested for 12 h at 37 °C using sequencing-grade trypsin (Promega). The peptides were extracted from the gel pieces by three 20 min incubations with a solution (30 μL) containing acetonitrile (50%) and formic acid (5%) in LC-MS-grade water with gentle agitation. The extracts were pooled and dried using a vacuum concentrator (Speed Vac Concentrator, SPD 111 V-230, Thermo Electron Corp.) and finally resuspended in LC-MS-grade water (15 μL) containing acetonitrile (3%) and formic acid (0.5%). accessed by following the link in the citation at the bottom of the page.
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LC-ESI-MS/MS and Data Analysis
LC-ESI-MS/MS was conducted using a nanoflow HPLC system (UltiMate 3000, Dionex) connected to a hybrid ion trap-orbitrap highresolution tandem mass spectrometer (Velos Pro, Thermo Scientific) operated in data-dependent acquisition (DDA) mode. Each sample (1 μL) was injected onto a capillary column (C18 Onyx Monolithic, 0.10 mm × 150 mm, Phenomenex) at a flow rate of 300 nL/min. Samples were sprayed at 1.6 kV using fused silica noncoated emitters (20 μm inside diameter with a 10 μm ID tip, PicoTip Emitter from New Objective). Chromatographic separation was achieved using a linear gradient from 3 to 35% solvent B in solvent A over 30 min and then increasing the level of solvent B to 95% over 5 min (solvent A consisted of 0.1% formic acid in water and solvent B 0.1% formic acid in acetonitrile). The raw data files were acquired (Xcalibur, Thermo Fisher) and exported to Proteome Discoverer software version 1.4 (Thermo Fisher) for peptide and protein identification using the Sequest database search algorithm. 27 Carbamidomethyl cysteine and oxidized methionines were selected as static and dynamic modifications, respectively. Peptide to spectrum match (PSM) validation was conducted using high-confidence XCorr threshold values of 1.9, 2.3, and 2.6 for doubly, triply, and more highly charged precursors.
Analysis of H297N MR-3-HP Reduced with NaCNBH3
H297N MR (0.98 mg/mL) was incubated with 3-HP (4.0 mM) in assay buffer at 25 °C for 30 min. Sodium cyanoborohydride (10 μL of a 1 M stock solution) was then added to the reaction mixture (total volume of 200 μL) to give a final concentration of 50 mM, and the pH was adjusted to 7.0 using HCl. The reaction mixture was then incubated for an additional 30 min. Finally, an aliquot of the reaction mixture (20 μL) was subjected to SDS-PAGE (12%) and analyzed using mass spectrometry as described above.
X-ray Crystallography
All crystals of wild-type MR were obtained at room temperature by the batch crystallization method. The protein solution consisted of accessed by following the link in the citation at the bottom of the page. 
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MR (6.0 mg/mL) purified as described above, in the presence of Na + -HEPES buffer (50 mM, pH 7.5) containing MgCl2 (3.3 mM) and 3-HP (20 mM). The batch reservoir solution was composed of sodium acetate (140 mM, pH 4.5), KCl (280 mM), and pentaerythritol propoxylate 426 (PEP 426; 46%). The protein solution and reservoir solution were gently mixed in a 1:1 ratio to a final volume of 20 μL, and 10 μL of this mixture was pipetted into a lightly greased crystallization well and sealed with a glass coverslip lined with mineral oil. Crystals grew spontaneously for 17 h, resulting in hexagonally shaped crystals. These crystals were looped directly from the wells to be flash-cooled in liquid nitrogen for storage.
Data Collection, Structure Determination, and Refinement
X-ray diffraction data for MR cocrystallized with 3-HP were collected at the Advanced Photon Source (APS) beamline LS-CAT-21-ID-G on a Rayonix MarMosaic 300 CCD detector, with an X-ray wavelength of 0.979 Å. Diffraction images were processed using HKL2000. 28 The structure was determined by molecular replacement using the wild-type MR enzyme [Protein Data Bank (PDB) 2MNR] as the search model with Phaser. 29 The molecular replacement models were extended by several rounds of manual model building with COOT 30 and refinement with REFMAC 31 using an automatically generated geometric/X-ray weighting term. Water molecules were added to the model in COOT with subsequent manual verification. On the basis of protein purification conditions and the well-established metal binding preference of MR, a Mg 2+ ion was modeled into the active site, despite the fact that a modeled Mg 2+ ion does not satisfy all of the observed electron density at this position.
Results and Discussion
Structure-Activity Study
We examined the effect of the α-keto acids 3-HP, mesoxalate, 3-fluoropyruvate (3-FP), and pyruvate on MR activity (Chart 1). Mesoxalate, which is fully hydrated in water (i.e., C2 gem-diol), 32 was a competitive inhibitor of MR with respect to (R)-mandelate [Ki = 1.8 accessed by following the link in the citation at the bottom of the page. 
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± 0.3 mM ( Figure 1S of the Supporting Information)], binding with the same affinity as tartronate (Ki = 1.8 mM), 23 suggesting that the glycolate-like moiety present in both ligands chelates the Mg 2+ and the second carboxylate forms a salt bridge with the active site Brønsted acid-base catalysts, thereby compensating for the loss of hydrophobic interactions. 23 Pyruvate, which exists as the keto form under the assay conditions, 33, 34 exhibited only 40% inhibition of MR activity at a concentration of 25 mM [i.e., Ki ≈ 20 mM, assuming competitive inhibition with 1 mM (R)-mandelate; Km = 1.2 mM]. This low binding affinity is similar to that of lactate (Ki ≈ 30 mM) 20 and likely arises because the methyl group is not sufficiently hydrophobic, nor can it form salt bridges with the Brønsted acid-base catalysts. MR bound 3-FP with an affinity [Ki = 1.3 ± 0.1 mM ( Figure 2S of the Supporting Information)] ∼15-fold greater than the affinity it exhibited for pyruvate, due to either dipolar interactions (rather than true Hbonds) 35, 36 with the active site acid-base catalysts or enhanced hydrophobic interactions. 37 In aqueous solutions, α-keto acids can exist as hydrates (gemdiols) to varying degrees. 33 The hydration state will determine the hybridization of C2 and could affect the binding of α-keto acids at the active site of MR. Pyruvate exists as the keto form (>92%) at pH 6.8, 33, 34 and benzoylformate (an α-keto acid examined previously) 38 is also expected to be in the keto form (>90%) at the assay pH. 39 Our observations that MR binds pyruvate (Ki ∼ 20 mM) and benzoylformate (Ki = 0.65 mM) 38 with affinities similar to those for lactate (Ki = 30 mM) 20 and (R)-mandelate (Km = 0.81 mM), 38 respectively, suggest that the enzyme does not distinguish between sp 2 and sp 3 hybridization at C2 in the ground state. Mesoxalate and 3-FP are 100% and >90% hydrated, respectively, in aqueous solutions. 32, [40] [41] [42] However, in the active site of MR, it is possible that coordination of the metal ion could lead to dehydration of the gem-diols, yielding the corresponding keto species. 43 It is unlikely, however, that this latter possibility would result in a significant alteration of the binding affinity considering our observations with pyruvate and lactate, and benzoylformate and mandelate, mentioned above. accessed by following the link in the citation at the bottom of the page.
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Inactivation by 3-HP Surprisingly, 3-HP (8.0 μM) showed time-dependent inhibition, while the other α-keto acids did not show such behavior at a concentration of 10 μM (Figure 1a ) or 2 mM ( Figure 3S of the Supporting Information). Dialysis of the inactive 3-HP-treated MR against assay buffer for ∼11 h did not restore enzymatic activity, indicating that the inactivation was irreversible. The inactivation of MR by 3-HP followed pseudo-first-order kinetics (Figure 1b) , and the observed pseudo-first-order rate constants (kobs) exhibited a linear dependence on the concentration of 3-HP (Figure 1c) . Saturation was not observed at 3-HP concentrations of ≤16 μM, and at higher concentrations of 3-HP, we were not able to obtain accurate kobs values because the loss of the MR activity was too rapid (relative to the assay duration of 3 min). Consequently, we were not able to differentiate between a kinetic mechanism for inactivation following a single step and a two-step mechanism with the reversible formation of a binary complex between MR and 3-HP. The slope from the plot of kobs versus the concentration of 3-HP gave an apparent second-order rate constant for inactivation (kinact/KI or k2) with a value of 83 ± 8 M -1 s -1 . The observed rate of inactivation by 3-HP was reduced in the presence of the reversible competitive inhibitor benzohydroxamate (BzH) (Figure 1d ), indicating that 3-HP likely binds at the active site. 0 μM) , and the initial rates were measured at the indicated time points as described above. The value for the control reaction, in the absence of 3-HP, is also shown (○). Experimental details may be found in Materials and Methods.
Site of Covalent Modification
To identify the residue(s) modified upon inactivation by 3-HP, 3-HP-modified MR (3-HP-MR) and an untreated sample of MR (control-MR) were subjected to SDS-PAGE followed by in-gel digestion with trypsin. The resulting proteolytic cleavage peptides were analyzed using LC-ESI-MS/MS. 
Mechanism of Inactivation
A possible mechanism accounting for our observations involves the reversible formation of a Schiff base (imine) between the ε-NH2 group of Lys 166 and the α-carbonyl of 3-HP [C2 mechanism (Scheme 2)], similar to the mechanism proposed for the inactivation of Nacetylneuraminate lyase (NAL) 44 and dihydrodipicolinate synthase (DHDPS) 45 by 3-HP. Subsequent deprotonation of the Schiff base (presumably by His 297) would yield an enol or enolate [i.e., enol(ate)] (86 Da), which could tautomerize to yield a covalent aldehyde adduct. Incubation of H297N MR with 3-HP, followed by treatment with NaCNBH3, and subsequent separation by SDS-PAGE and analysis using LC-ESI-MS/MS revealed that Lys 166 of the TKpeptide was modified by a group with a mass of 88 Da (Figure 2c) , consistent with reduction of the Schiff base and in accord with the proposed inactivation mechanism. In addition, we observed two 88 Da adducts arising from the nonspecific modification of Lys 207 and Lys 238 located away from the dimer interface on the surface of the enzyme (data not shown). Such adducts would be expected considering that imines may form spontaneously at other sites bearing a primary amino group. 46, 47 Scheme 2. Proposed Mechanisms for Inactivation of MR by 3-HP Giving Rise to an 86 Da Adduct permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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Alternatively, 3-HP may undergo tautomerization either in solution or within the active site to yield tartronate semialdehyde. 48 Schiff-base formation between Lys 166 and the aldehyde [C3 mechanism (Scheme 2)], followed by deprotonation, also yields an adduct with a mass of 86 Da and is consistent with our LC-ESI-MS/MS observations.
Structural Studies
To distinguish between these two mechanistic possibilities, we determined the X-ray crystal structure of MR inactivated by 3-HP at 1.65 Å resolution ( Table 1 ). The electron density clearly indicates bond formation occurs between the ε-NH2 group of Lys 166 and C2 of 3-HP in accord with the C2 mechanism ( Figure 3 and Figure 4S of the Supporting Information). The structure was refined by defining a single bond between the ε-NH2 group of Lys 166 and C2 of 3-HP, and the 3-HP adduct was further refined in two alternative conformations: major (70%) and minor (30%) conformations of either the (E)-enol(ate) or the aldehyde. Although it is not possible to determine whether the product adduct exists as the aldehyde or enol(ate) tautomer from the crystal structure, the enol(ate) may be preferred because enolase, which has a similar active site architecture, is strongly inhibited by the enolate of d-tartronate semialdehyde phosphate. 49, 50 Certainly, the active site of MR is optimized to stabilize an enolate in accord with its ability to catalyze racemization, and Nε2 of His 297 is 2.9 Å from the terminal oxygen of the major adduct so that it is capable of stabilizing the enol(ate) through H-bonding (Figure 3 ). The inability of 3-FP to inactivate MR indicates that the formation of either the enol(ate) or aldehyde by 3-HP is essential for inactivation. C2 of the 3-HP enamine occupies a position approximately equivalent to that of the α-methyl group of (S)-atrolactate ( Figure 4 ). Both ground state and transition state analogues bind to MR with one carboxylate oxygen and the α-OH group coordinated to Mg 2+ in the active site. In the 3-HP-MR structure, however, the α-OH group is replaced with a free water molecule, while one carboxylate oxygen maintains coordination with Mg 2+ in a manner analogous to that of the substrate and transition state analogues. This coordination with the active site Mg 2+ likely facilitates deprotonation of the Schiff base by His 297, similar to its role in stabilizing the aci-carboxylate intermediate during the racemization of mandelate. Interestingly, the active site lid (20s loop) that typically closes over the active site when either ground state or transition state analogues are bound adopts an "open" conformation in the 3-HP-MR structure ( Figure 5 ). This conformation may arise because the hydrophobic group (i.e., aromatic ring) present on substrates and intermediate analogues is not present to drive lid closure. 51 The 20s loop in the structure of MR (PDB entry 4M6U) with bound tartronate, which also lacks the phenyl ring, exhibited an approximately 1:1 ratio of both the open and closed conformations; 23 however, it is important to note that the 20s loop of MR with only sulfate bound (PDB entry 2MNR) was closed, suggesting that other factors may also contribute to the observed conformation of the loop in crystals. 8 VERSION; this is the author's final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page. 
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(PDB entry 4HNC, yellow). 23 Aside from 3-HP, all other ligands are not shown for the sake of clarity. The 3-HP-MR structure exhibits an "open" conformation of the 20s loop lid, similar to the conformation observed when the bulky substrate-product analogue benzilate is bound to C92S/C264S/K166C MR. 23 
Mechanistic Link between Superfamilies
The formation of a Schiff base is unprecedented in the enolase superfamily. However, irreversible inhibition by 3-HP has been demonstrated for members of the NAL superfamily. This superfamily includes NAL, DHDPS, trans-o-hydroxybenzylidene-pyruvate hydratase-aldolase, and d-4-deoxy-5-oxoglucarate dehydratase, 2, 7, 52 which have also been included within the class I aldolases 53 by the SCOP database 54, 55 on the basis of their similar Schiff-base chemistry and common (α/β)8-fold. 3-HP inactivates NAL from Clostridium fringens 56 and E. coli 44 and DHDPS from E. coli, 45 and the X-ray crystal structures of the covalently modified NAL and DHDPS enzymes revealed the presence of an aldehyde/enol(ate)-lysine adduct similar to the one we observe for MR inactivated by 3-HP. 44, 45 Although the mechanism-based inhibition of these two NAL superfamily members by 3-HP also proceeds via initial Schiff-base formation followed by deprotonation, 44, 45 the apparent second-order rate constant for the inactivation of MR exceeds that observed for inactivation of DHDPS (0.56 M -1 s -1 ) by ∼138-fold. This observation is in accord with the active site of MR being optimized to promote enolate formation.
Many of the enzymes sharing the highly prevalent (α/β)8-barrel (or TIM barrel) folding topology 53, [57] [58] [59] [60] [61] [62] are believed to have arisen via divergent evolution from a common ancestor or a limited number of progenitor enzymes. 53, 60, [63] [64] [65] [66] [67] Many aldolases share this fold with members of the enolase and NAL superfamilies, as well as sharing a similar mechanistic theme, i.e., the formation of a "masked" carbanionic intermediate (Scheme 3). Formation of such an intermediate is facilitated via formation of an imine/enamine "electron sink" with an active site lysine residue in the class I aldolases, and by utilizing a transition metal ion (usually Zn 2+ ) as an essential Lewis acid cofactor in the class II aldolases. Although the reaction mechanisms differ between these two classes of aldolases, their ancestral aldolase has been postulated to have been a Schiff-base-forming enzyme that subsequently gave rise to a lineage of metal-dependent class II permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from American Chemical Society.
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aldolases. 53 Several comparisons of sequences, structures, and functions have suggested common ancestry between the class I and II aldolases and the enolase superfamily. 53, 57, 63, 67 Considering the metal ion dependence of the class II aldolases, the mechanistic link to the enolase superfamily was clear (Scheme 3), 68 but such a link between the class I aldolases and the enolase superfamily was not evident. Allen and co-workers conducted a comparison of the primary and tertiary structures of class I aldolases and members of the NAL superfamily, and concluded that these enzymes could all be included in a large superfamily utilizing Schiff-base chemistry and related by divergent evolution from a common progenitor enzyme. 69 Interestingly, these authors employed MR as a "negative control" because it was deemed not to be mechanistically related to the aldolases. This study suggests that a mechanistic relationship does indeed exist. Thus, while over evolutionary time scales the catalytic mechanism of enzymes may not be fully conserved, 67 the ability of MR to form and deprotonate a Schiff-base intermediate furnishes a mechanistic link to other α/β-barrel enzymes utilizing Schiff-base chemistry and may be a relic of an activity possessed by a promiscuous progenitor enzyme. 70 Delineating such chemistry-based relationships and their overlap with structure space and sequence space affords a more complete understanding of nature's strategies for the evolution of new catalysts. 
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